References
- Alves Pinto de Andrade, D., et al., 2022. Reassessment of low- and intermediate-risk endometrial cancer reports by gynecological pathologists increases risk classification without impacting outcome. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 278, 172–176.
- Auer, R.L., et al., 2005. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes, Chromosomes & Cancer, 43 (1), 1–10.
- Börner, C., et al., 2018. Pain mechanisms in peritoneal diseases might be partially regulated by estrogen. Reproductive Sciences, 25 (3), 424–434.
- Buanne, P., et al., 2000. Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics, 68 (3), 253–263.
- Chu, T., et al., 2012. Effect of ovarian stimulation on oocyte gene expression in cattle. Theriogenology, 77 (9), 1928–1938.
- Dellino, M., et al., 2021. A strengthening the reporting of observational studies in epidemiology (STROBE): are HE4 and CA 125 suitable to detect a Paget disease of the vulva? Medicine, 100 (5), e24485.
- Dong, W., et al., 2009. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochemical and Biophysical Research Communications, 387 (1), 132–138.
- Elis, S., et al., 2008. Search for the genes involved in oocyte maturation and early embryo development in the hen. BMC Genomics., 9, 110.
- Fagotti, A., et al., 2020. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 30 (11), 1657–1664.
- Giannini, A., et al., 2022. Advances on prevention and screening of gynecologic tumors, are we stepping forward? Healthcare, 10 (9), 1605.
- Khoramdad, M., et al., 2022. Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies. European Journal of Medical Research, 27 (1), 311.
- Králíčková, M., et al., 2020. Endometriosis and risk of ovarian cancer: what do we know? Archives of Gynecology and Obstetrics, 301 (1), 1–10.
- Laganà, A.S., et al., 2015. Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. European Journal of Gynaecological Oncology, 36 (5), 495–505.
- Laganà, A.S., et al., 2016. Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecologic Oncology Reports, 18, 57–58.
- Li, Y., et al., 2022. MSLN correlates with immune infiltration and chemoresistance as a prognostic biomarker in ovarian cancer. Frontiers in Oncology, 12, 830570.
- Liu, R., et al., 2021. A novel homozygous missense variant in BTG4 causes zygotic cleavage failure and female infertility. Journal of Assisted Reproduction and Genetics, 38 (12), 3261–3266.
- Liu, Y., et al., 2016. BTG4 is a key regulator for maternal mRNA clearance during mouse early embryogenesis. Journal of Molecular Cell Biology, 8 (4), 366–368.
- Mano, H., et al., 2015. Age-related decrease of IF5/BTG4 in oral and respiratory cavities in mice. Bioscience, Biotechnology, and Biochemistry, 79 (6), 960–968.
- Mori, Y., et al., 2011. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine-Related Cancer, 18 (4), 465–478.
- Mulongo, M., et al., 2022. Prevention of cervical cancer in low-resource African settings. Obstetrics and Gynecology Clinics of North America, 49 (4), 771–781.
- Pasternak, M., et al., 2016. The BTG4 and CAF1 complex prevents the spontaneous activation of eggs by deadenylating maternal mRNAs. Open Biology, 6 (9), 160184.
- Pennetier, S., et al., 2005. Genes preferentially expressed in bovine oocytes revealed by subtractive and suppressive hybridization. Biology of Reproduction, 73 (4), 713–720.
- Räty, M., et al., 2011. In vitro maturation supplements affect developmental competence of bovine cumulus-oocyte complexes and embryo quality after vitrification. Cryobiology, 63 (3), 245–255.
- Seo, J.S., et al., 2017. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells. BMC Molecular and Cell Biology, 18 (1), 14.
- Szász, A.M., et al., 2016. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget, 7 (31), 49322–49333.
- Toyota, M., et al., 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Research, 68 (11), 4123–4132.
- Winkler, G.S., 2010. The mammalian anti-proliferative BTG/Tob protein family. Journal of Cellular Physiology, 222 (1), 66–72.
- Yu, C., et al., 2016. BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes. Nature Structural & Molecular Biology, 23 (5), 387–394.
- Zhang, N., et al., 2020. BTG4 is a novel p53 target gene that inhibits cell growth and induces apoptosis. Genes (Basel), 11 (2), 217.
- Zheng, W., et al., 2020. Homozygous mutations in BTG4 cause zygotic cleavage failure and female infertility. American Journal of Human Genetics, 107 (1), 24–33.
- Zhu, Y., et al., 2014. TCGA-assembler: open-source software for retrieving and processing TCGA data. Nature Methods, 11 (6), 599–600.